Article citationsMore>>

Lambiase, P.D., De Bono, J., Lowe, M., Turley, A., Slade, A., Collinson, J., Rajappan, K., Harris, S., Collinson, J., Carpenter, V., Daw, H., Hall, A., Roberts, E., Holding, S., Paisey, J., Sopher, M., Wrigh, I., Wiles, B. and Taylor, D. (2019) British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication. Arrhythmia & Electrophysiology Review, 8, 161-165.
https://doi.org/10.15420/aer.2019.8.3.G1

has been cited by the following article:

• TITLE: Slow and Steady: The Cautious Use of Neuroleptics in a Patient with Andersen-Tawil Syndrome

  AUTHORS: Fahad Alkhalfan, Bharadwaj Adithya-Sateesh, Girma M. Ayele, Merve Otles, Rediet T. Atalay, Miriam Michael

  KEYWORDS: Long Q-T Schizophrenia, Neuroleptic, Anderson Tawil Syndrome, Congenital Long QT Syndrome

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.10, October 9, 2022

  ABSTRACT: Long QT syndrome (LQT) is a disease of cardiac repolarization caused by alterations in the transmembrane potassium and sodium currents. This results in prolongation of the QT interval on electrocardiography (EKG) and can result in torsade de pointes and sudden cardiac death. We present a case of a patient who has Anderson Tawil syndrome; a congenital long QT syndrome, with a history of cardiac arrhythmias who developed acute paranoid schizophrenia that was refractory to treatment with non-QT-prolonging drugs and required institution of neuroleptics to control her psychiatric symptoms.